Australia markets close in 4 hours 31 minutes

INVO Bioscience, Inc. (INVO)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.0100+0.0932 (+10.17%)
At close: 04:00PM EDT
0.9603 -0.05 (-4.92%)
After hours: 07:33PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-8,035
-8,035
-10,893
-6,655
-8,347
Depreciation & amortisation
200.894
200.894
77.301
166.082
34.481
Stock-based compensation
1,393
1,393
2,224
2,708
1,757
Change in working capital
471.699
471.699
1,482
-3,606
-845.524
Accounts receivable
-63.401
-63.401
-26.679
-28.771
-14.141
Inventory
-0.905
-0.905
24.171
-22.401
-163.985
Accounts payable
924.678
924.678
904.06
114.495
-42.603
Other working capital
-5,200
-5,200
-6,616
-6,485
-4,864
Other non-cash items
900.128
900.128
172.644
1,188
2,626
Net cash provided by operating activities
-4,755
-4,755
-6,603
-6,030
-4,775
Cash flows from investing activities
Investments in property, plant and equipment
-444.722
-444.722
-12.728
-454.649
-88.93
Acquisitions, net
-2,050
-2,050
-68.489
-1,699
-98.084
Other investing activities
-
-
-
-
-0.24
Net cash used for investing activities
-2,495
-2,495
-81.217
-2,154
-187.254
Cash flows from financing activities
Debt repayment
-1,495
-1,495
0
-250
-810
Common stock issued
5,702
5,702
289.8
3,651
11,475
Net cash used provided by (used for) financing activities
7,392
7,392
1,090
3,771
13,822
Net change in cash
142.289
142.289
-5,595
-4,413
8,859
Cash at beginning of period
90.135
90.135
5,685
10,098
1,239
Cash at end of period
232.424
232.424
90.135
5,685
10,098
Free cash flow
Operating cash flow
-4,755
-4,755
-6,603
-6,030
-4,775
Capital expenditure
-444.722
-444.722
-12.728
-454.649
-88.93
Free cash flow
-5,200
-5,200
-6,616
-6,485
-4,864